EUVIMEDEUVIMED entdecken
Crossref

Amphiphilic Acyclic Cucurbit[ n ]uril: Synthesis, Self-Assembly, and Chemotherapeutic Delivery to Overcome Multidrug Resistance

Zizhen Zhao, Danying Ma, Shuyi Wang, Wei Zhou iD, Dan-Wei Zhang iD, Zhan-Ting Li iD, Da Ma iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Zizhen Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Fudan University, 220 Handan Road, Shanghai 200433, China. Hauptthemen laut MEDLINE: Doxorubicin, Drug Resistance, Multiple, Bridged-Ring Compounds, Imidazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new amphiphilic acyclic cucurbit[n]uril (CB[n]) is designed and synthesized. This amphiphilic acyclic CB[n] could encapsulate pharmaceutical drugs via a host-guest interaction. Self-assembly of this acyclic CB[n] forms spherical nanoparticles with diameters of 91 nm in water. The self-assembled nanoparticles are capable of delivering doxorubicin with high efficiency. Cell experiments show that the doxorubicin-loaded nanoparticles can improve cellular uptake and cytotoxicity by using the MCF-7/ADR cell line. The A549 tumor-bearing mouse model shows that self-assembled nanoparticles help overcome multidrug resistance in vivo. Cell study and histological assays confirm the biocompatibility of self-assembled nanoparticles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDrug Resistance, MultipleBridged-Ring CompoundsImidazolesDrug Resistance, NeoplasmHumansAnimalsMiceNanoparticlesMCF-7 CellsA549 CellsCell Line, TumorDrug CarriersDrug Delivery SystemsFemaleXenograft Model Antitumor AssaysHeterocyclic Compounds, 2-RingMacrocyclic CompoundsImidazolidinesCucurbit(n)urils

Stichwörter der Autor:innen

chemotherapycucurbit[n]urildrug deliverymultidrug resistanceself-assembly

Substanzen

DoxorubicinBridged-Ring CompoundsImidazolesDrug CarriersHeterocyclic Compounds, 2-RingMacrocyclic CompoundsImidazolidinesCucurbit(n)urils

Autor:innen und Institutionen

  • Department of Chemistry, Fudan University, 220 Handan Road, Shanghai 200433, China.
  • School of Pharmaceutical and Chemical Engineering & Institute for Advanced Studies, Taizhou University, 1139 Shifu Avenue, Taizhou 318000 Zhejiang, China.

ORCID-Profile: Wei Zhou, Dan-Wei Zhang, Zhan-Ting Li, Da Ma

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zhao, Z., Ma, D., Wang, S., Zhou, W., Zhang, D. W., Li, Z. T., & Ma, D. (2025). Amphiphilic Acyclic Cucurbit[ n ]uril: Synthesis, Self-Assembly, and Chemotherapeutic Delivery to Overcome Multidrug Resistance. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00012

Vancouver

Zhao Z, Ma D, Wang S, Zhou W, Zhang DW, Li ZT, et al. Amphiphilic Acyclic Cucurbit[ n ]uril: Synthesis, Self-Assembly, and Chemotherapeutic Delivery to Overcome Multidrug Resistance. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00012

BibTeX
@article{Zhao2025,
  author = {Zhao, Zizhen and Ma, Danying and Wang, Shuyi and Zhou, Wei and Zhang, Dan-Wei and Li, Zhan-Ting and Ma, Da},
  title = {Amphiphilic Acyclic Cucurbit[ n ]uril: Synthesis, Self-Assembly, and Chemotherapeutic Delivery to Overcome Multidrug Resistance},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00012}
}
Kostenlos starten →